Skip to content

Enteral Feeding Study of Formula Containing Fish Oil in Critical Care Setting

Use of a High-protein Enteral Formula Containing Prebiotics and Fish Oil in Critical Care

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00421941
Enrollment
50
Registered
2007-01-15
Start date
2007-01-31
Completion date
2008-08-31
Last updated
2013-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma, Tube Feeding

Keywords

enteral feeding, critical care, fish oil, surgical

Brief summary

The purpose of this study is to evaluate the clinical applicability of an enteral tube feeding formula containing fish oil and prebiotics in a critical care population.

Detailed description

In terms of nutrition support in the acute care setting, it is generally accepted that 1. earlier is better 2. enteral is superior to parenteral 3. the quality of nutrients appears more important than quantity 4. select populations will show additional benefit from specific nutrient supplementation. The current study is designed to evaluate the tolerance of an enteral formula in trauma and surgery patients, as demonstrated by achieving and maintaining enteral feeding goal, gastrointestinal tolerance and inflammatory markers.

Interventions

PROCEDURETube feeding

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 18 - 70 years old * New ICU admit * Enteral tube feeding anticipated for at least 7 days * Informed consent

Exclusion criteria

* Enteral tube feeding immediately prior to admit * Parenteral feeding * Medical condition that preclude receiving tube feeding or formula * Determined by PI to be inappropriate * Participating in another clinical trial

Design outcomes

Primary

MeasureTime frame
Clinical applicability as measured by the length of time between start of feeding to the first achievement of 800ml/day

Secondary

MeasureTime frame
Gastrointestinal tolerance
Time to advance to full feed
Inflammatory markers
Infection

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026